Publications by authors named "Javier Rejas"

Claim this Profile
Q
Quality of life measures in Parkinson's disease: a systematic literature review of patient-reported outcomes measures (PROMs) and their psychometric properties.
Alberto de la Cuadra-Grande, Javier Rejas, Miguel Ángel Casado, Manuel Monroy, Miguel Ruiz

J Neurol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Menopause in adult women with human papillomavirus: health-related quality of life and determinants.
Javier Calvo-Torres, Javier Rejas, Mar Ramírez-Mena, Carmen González-Granados, Melissa Bradbury

Menopause· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
All-cause community acquired pneumonia cost by age and risk in real-world conditions of care in Spain.
Javier Rejas, Antoni Sicras-Mainar, Aram Sicras-Navarro, Nadia Lwoff, Cristina Méndez

Expert Rev Pharmacoecon Outcomes Res· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adherence to Desvenlafaxine Versus Usual Care and Its Impact on Health Outcomes: A Comparative Real-world Clinical Study.
Narcís Cardoner, Antoni Sicras-Mainar, Javier Rejas, Beatriz Armada

Clin Drug Investig· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive and criterion validity of the Cervantes-SF menopause quality of life questionnaire.
Pluvio J Coronado, Manuel Monroy, María Fasero, Laura Baquedano, Nicolás Mendoza, Javier Rejas

Menopause· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population-based norms for the Cervantes-SF short-form questionnaire assessing health-related quality of life in menopause.
Pluvio J Coronado, Manuel Monroy, María Fasero, Rafael Sánchez-Borrego, Santiago Palacios, Javier Rejas

Maturitas· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing health-related quality of life in patients with breast cancer: a reply to Ribi et al.
Stefano Maratia, Sergio Cedillo, Javier Rejas

Qual Life Res· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mapping of the Gastrointestinal Short Form Questionnaire (GSF-Q) into EQ-5D-3L and SF-6D in patients with gastroesophageal reflux disease.
Manuel Monroy, Miguel A Ruiz, Javier Rejas, Javier Soto

Health Qual Life Outcomes· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing health-related quality of life in patients with breast cancer: a systematic and standardized comparison of available instruments using the EMPRO tool.
Stefano Maratia, Sergio Cedillo, Javier Rejas

Qual Life Res· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness analysis of fesoterodine flexible dose in newly diagnosed patients with overactive bladder in routine clinical practice in Spain.
Carmen Peral, Francisco Sánchez-Ballester, José M García-Mediero, Jaime Ramos, Javier Rejas

Clinicoecon Outcomes Res· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Budgetary impact analysis on funding smoking-cessation drugs in patients with COPD in Spain.
Carlos A Jiménez-Ruiz, Segismundo Solano-Reina, Jaime Signes-Costa, Eva de Higes-Martinez, José I Granda-Orive, Javier Rejas

Int J Chron Obstruct Pulmon Dis· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modeling the longitudinal latent effect of pregabalin on self-reported changes in sleep disturbances in outpatients with generalized anxiety disorder managed in routine clinical practice.
Miguel A Ruiz, Enrique Álvarez, Jose L Carrasco, José M Olivares, María Pérez, Javier Rejas

Drug Des Devel Ther· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mapping of the OAB-SF Questionnaire onto EQ-5D in Spanish Patients with Overactive Bladder.
Miguel A Ruiz, Laura L Gutiérrez, Manuel Monroy, Javier Rejas

Clin Drug Investig· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Psychometric attributes of the Cervantes short-form questionnaire for measuring health-related quality of life in menopausal women.
Pluvio J Coronado, Rafael Sánchez-Borrego, Miguel A Ruiz, Laura Baquedano, Sonia Sánchez, Javier Rejas

Maturitas· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost Effectiveness of the 13-Valent Pneumococcal Conjugate Vaccination Program in Chronic Obstructive Pulmonary Disease Patients Aged 50+ Years in Spain.
Jose Miguel Rodríguez González-Moro, Rosario Menéndez, Magda Campins, Nadia Lwoff, Itziar Oyagüez, Javier Rejas

Clin Drug Investig· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disability-adjusted-life-years losses in postmenopausal women with osteoporosis: a burden of illness study.
Josep Darbà, Lisette Kaskens, Nuria Pérez-Álvarez, Santiago Palacios, José Luis Neyro, Javier Rejas

BMC Public Health· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modeling the predictive value of pain intensity on costs and resources utilization in patients with peripheral neuropathic pain.
Concepción Pérez, Ana Navarro, María T Saldaña, Koo Wilson, Javier Rejas

Clin J Pain· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structural validity of a 16-item abridged version of the Cervantes Health-Related Quality of Life scale for menopause: the Cervantes Short-Form Scale.
Pluvio J Coronado, Rafael Sánchez Borrego, Santiago Palacios, Miguel A Ruiz, Javier Rejas

Menopause· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disability in bipolar I disorder: the 36-item World Health Organization Disability Assessment Schedule 2.0.
Georgina Guilera, Juana Gómez-Benito, Óscar Pino, Emilio Rojo, Eduard Vieta, Javier Rejas

J Affect Disord· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and economic outcomes of adjunctive therapy with pregabalin or usual care in generalized anxiety disorder patients with partial response to selective serotonin reuptake inhibitors.
Enrique Álvarez, José M Olivares, José L Carrasco, Vanessa López-Gómez, Javier Rejas

Ann Gen Psychiatry· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Psychometric validation of the OAB-V8 and OAB-V3 scales for the screening of patients with probable overactive bladder in the Spanish population].
Francisco J Brenes, Javier C Angulo, David Ochayta, Javier Rejas, Daniel Arumí

Med Clin (Barc)· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost effectiveness of fesoterodine and tolterodine for the treatment of overactive bladder with urge urinary incontinence in Spain and Finland.
Javier C Angulo, Antti Valpas, Javier Rejas, Kari Linden, Marion Kvasz

Clin Drug Investig· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antimuscarinic persistence patterns in newly treated patients with overactive bladder: a retrospective comparative analysis.
Antoni Sicras-Mainar, Javier Rejas, Ruth Navarro-Artieda, Alba Aguado-Jodar, Amador Ruiz-Torrejón

Int Urogynecol J· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and resource utilization patterns in patients with refractory neuropathic pain prescribed pregabalin for the first time in routine medical practice in primary care settings in Spain.
Concepción Pérez, Ana Navarro, María T Saldaña, Xavier Masramón, María Pérez, Javier Rejas

Pain Med· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health economics perspective of fesoterodine, tolterodine or solifenacin as first-time therapy for overactive bladder syndrome in the primary care setting in Spain.
Antoni Sicras-Mainar, Javier Rejas, Ruth Navarro-Artieda, Alba Aguado-Jodar, Amador Ruiz-Torrejón

BMC Urol· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis